Similar articles for PMID: 16945373

Year	Number of Results
1999	1
2000	3
2001	1
2002	3
2003	2
2004	2
2005	5
2006	8
2007	5
2008	7
2009	5
2010	3
2011	1
2012	2
2013	3
2014	3
2015	5
2016	1
2020	1
2021	1
2022	2
2024	0

1

Codon 54 polymorphism of the fatty acid binding protein (FABP) 2 gene is associated with increased cardiovascular risk in the dyslipidemic diabetic participants of the Veterans Affairs HDL intervention trial (VA-HIT).

Georgopoulos A, Bloomfield H, Collins D, Brousseau ME, Ordovas JM, O'Connor JJ, Robins SJ, Schaefer EJ. Georgopoulos A, et al. Atherosclerosis. 2007 Sep;194(1):169-74. doi: 10.1016/j.atherosclerosis.2006.07.022. Epub 2006 Aug 30. Atherosclerosis. 2007. PMID: 16945373 Clinical Trial.

2

The L162V polymorphism at the peroxisome proliferator activated receptor alpha locus modulates the risk of cardiovascular events associated with insulin resistance and diabetes mellitus: the Veterans Affairs HDL Intervention Trial (VA-HIT).

Tai ES, Collins D, Robins SJ, O'Connor JJ Jr, Bloomfield HE, Ordovas JM, Schaefer EJ, Brousseau ME. Tai ES, et al. Atherosclerosis. 2006 Jul;187(1):153-60. doi: 10.1016/j.atherosclerosis.2005.08.034. Epub 2005 Oct 10. Atherosclerosis. 2006. PMID: 16221474 Clinical Trial.

3

Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT).

Rubins HB, Robins SJ, Collins D, Nelson DB, Elam MB, Schaefer EJ, Faas FH, Anderson JW. Rubins HB, et al. Arch Intern Med. 2002 Dec 9-23;162(22):2597-604. doi: 10.1001/archinte.162.22.2597. Arch Intern Med. 2002. PMID: 12456232 Clinical Trial.

4

Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT).

Robins SJ, Rubins HB, Faas FH, Schaefer EJ, Elam MB, Anderson JW, Collins D; Veterans Affairs HDL Intervention Trial (VA-HIT). Robins SJ, et al. Diabetes Care. 2003 May;26(5):1513-7. doi: 10.2337/diacare.26.5.1513. Diabetes Care. 2003. PMID: 12716814 Clinical Trial.

5

Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.

Robins SJ, Collins D, Nelson JJ, Bloomfield HE, Asztalos BF. Robins SJ, et al. Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1172-8. doi: 10.1161/ATVBAHA.107.160739. Epub 2008 Mar 20. Arterioscler Thromb Vasc Biol. 2008. PMID: 18356553

6

Gemfibrozil for secondary prevention of cardiovascular events in mild to moderate chronic renal insufficiency.

Tonelli M, Collins D, Robins S, Bloomfield H, Curhan GC; Veterans' Affairs High-Density Lipoprotein Intervention Trial (VA-HIT) Investigators. Tonelli M, et al. Kidney Int. 2004 Sep;66(3):1123-30. doi: 10.1111/j.1523-1755.2004.00862.x. Kidney Int. 2004. PMID: 15327407 Free article. Clinical Trial.

7

Body weight, plasma insulin, and coronary events with gemfibrozil in the Veterans Affairs High-Density Lipoprotein Intervention Trial (VA-HIT).

Robins SJ, Collins D, McNamara JR, Bloomfield HE. Robins SJ, et al. Atherosclerosis. 2008 Feb;196(2):849-55. doi: 10.1016/j.atherosclerosis.2007.01.029. Epub 2007 Mar 1. Atherosclerosis. 2008. PMID: 17335828 Clinical Trial.

8

Polymorphism of the FABP2 gene: a population frequency analysis and an association study with cardiovascular risk markers in Argentina.

Gomez LC, Real SM, Ojeda MS, Gimenez S, Mayorga LS, Roqué M. Gomez LC, et al. BMC Med Genet. 2007 Jun 26;8:39. doi: 10.1186/1471-2350-8-39. BMC Med Genet. 2007. PMID: 17594477 Free PMC article.

9

FABP2 Ala54Thr polymorphism and diabetes in Chilean elders.

Albala C, Villarroel A, Santos JL, Angel B, Lera L, Liberman C, Sanchez H, Pérez-Bravo F. Albala C, et al. Diabetes Res Clin Pract. 2007 Aug;77(2):245-50. doi: 10.1016/j.diabres.2006.12.006. Epub 2007 Feb 12. Diabetes Res Clin Pract. 2007. PMID: 17292994

10

Risk factors for primary prevention of cardiovascular disease and risk reduction by lipid control: the OMEGA study risk factor sub-analysis.

Teramoto T, Kawamori R, Miyazaki S, Teramukai S, Mori Y, Okuda Y, Hiramatsu K; OMEGA Study Group. Teramoto T, et al. Clin Exp Hypertens. 2014;36(4):236-43. doi: 10.3109/10641963.2013.810226. Epub 2013 Jul 18. Clin Exp Hypertens. 2014. PMID: 23865387

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

56 results

Results by year